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Aging increases the risk of tuberculosis (TB) and its adverse outcomes, but most studies
are based on secondary analyses, and few are in Hispanics. Diabetes is a risk factor for TB
in adults, but its contribution in the elderly is unknown. We aimed to identify the role of diabe-
tes and other risk factors for TB in elderly Hispanics.
Methods
Cross-sectional study among newly-diagnosed TB patients, recent contacts (ReC), or com-
munity controls (CoC) totaling 646 participants, including 183 elderly (>60 years; 43 TB, 80
ReC, 60 CoC) and 463 adults (18 to 50 years; 80 TB, 301 ReC and 82 CoC). Host character-
istics associated with TB and latent Mycobacterium tuberculosis infection (LTBI) were identi-
fied in the elderly by univariable and confirmed by multivariable logistic regression.
Results
LTBI was more prevalent among the elderly CoC (55% vs. 23.2% in adults; p<0.001), but
not in ReC (elderly 71.3% vs. adult 63.8%); p = 0.213). Risk factors for TB in the elderly
included male sex (adj-OR 4.33, 95% CI 1.76, 10.65), smoking (adj-OR 2.55, 95% CI 1.01,
6.45) and low BMI (adj-OR 12.34, 95% CI 4.44, 34.33). Unexpectedly, type 2 diabetes was
not associated with TB despite its high prevalence (adj-OR 0.38, 95% CI 0.06, 2.38), and
BCG vaccination at birth was protective (adj-OR 0.16, 95% CI 0.06, 0.45).
PLOS ONE







Citation: Scordo JM, Aguillón-Durán GP, Ayala D,
Quirino-Cerrillo AP, Rodrı́guez-Reyna E, Mora-
Guzmán F, et al. (2021) A prospective cross-
sectional study of tuberculosis in elderly Hispanics
reveals that BCG vaccination at birth is protective
whereas diabetes is not a risk factor. PLoS ONE
16(7): e0255194. https://doi.org/10.1371/journal.
pone.0255194
Editor: Frederick Quinn, The University of Georgia,
UNITED STATES
Received: May 27, 2021
Accepted: July 10, 2021
Published: July 29, 2021
Copyright: © 2021 Scordo et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: This work was supported by the National
Institute of Aging (NIA) at the National Institutes of
Health [P01-AG051428 to JT, BIR, LSS and JBT]
and National Institute of Health (NIH)/NIA NRSA
T32-AG021890 to JMS. URL: https://www.nia.nih.
gov/research/grants-funding The funders had no
Conclusions
We report novel distinctions in TB risk factors in the elderly vs. adults, notably in diabetes
and BCG vaccination at birth. Further studies are warranted to address disparities in this vul-
nerable, understudied population.
Introduction
Aging is associated with immune function decline consequent to cellular immunosenescence
and inflammaging, and is identified as a risk factor for respiratory tract infections such as
tuberculosis (TB) [1, 2]. TB caused an estimated 1.4 million deaths and 10 million new cases in
2019. Approximately one-fourth of the world’s population has latent Mycobacterium tubercu-
losis infection (LTBI) [3]. The relative risk of TB in the elderly is 1.5-fold higher than in adults
(21 to 64 years old), and the risk of mortality is� 5-fold higher, with rates ranging from 20 to
30% [4–6]. Elderly patients are difficult to diagnose due to the lack of classical symptoms and
to impaired or reduced responses to diagnostics such as the tuberculin skin test. This leads to
frequent delays in treatment initiation and in some cases to post-mortem diagnosis [7–9].
Most studies in older people with TB are based on secondary analysis of data [10–12].
These studies have identified risk factors for TB in the elderly, including aging itself, male sex,
smoking, and malnutrition, undernutrition or low body mass index (BMI) [11]. Although dia-
betes increases the risk of TB by 3-fold among adults [13], the link between TB and diabetes in
the elderly has not been formally studied. Instead, association studies among all adults suggest
a stronger link to diabetes among middle-aged vs. older adults (e.g.� 60 years) [14–17]. Our
prior studies among Hispanics in the states of Tamaulipas (Mexico) and Texas (US) identified
diabetes as a major contributor to TB, with a 25% population attributable risk fraction [17],
but elderly individuals were mostly excluded [18].
Here we sought to identify risk factors for LTBI or TB among the elderly in a Hispanic com-
munity across the US-Mexico border [19]. We conducted a cross-sectional study with enroll-
ment of newly-diagnosed TB patients, recent contacts (ReC), and community controls (CoC)
among elderly individuals (>60 years), and used adults (18 to 50 years old) as reference. We
found shared risk factors for TB between the elderly and adult populations, but most impor-
tantly, we identified unique aspects in the elderly, most notably the lack of association between
TB and diabetes and a potential protective role of BCG vaccination at birth.
Methods
Ethical statement
This study was approved by the institutional review boards in Mexico (SST/SCAME/DCES/
597/2017, Secretarı́a de Salud de Tamaulipas) and the United States (HSC-SPH-17-0990, Uni-
versity of Texas Health Houston), and all participants signed an informed consent.
Participant enrollment and characteristics
Adults (18 to 50 years) and elderly (>60 years) participants were enrolled at pulmonary and
community clinics in South Texas and northern Tamaulipas, Mexico, between 2017 and 2020.
Participants included newly-diagnosed active pulmonary TB patients enrolled prior to or
within one week of TB treatment (TB), recent TB contacts (ReC), and community controls
(CoC) (Fig 1). TB diagnosis was based on isolation of M. tuberculosis or positive sputum smear
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(laboratory diagnosis), or by clinical symptoms consistent with pulmonary TB and an abnor-
mal chest X-ray (clinical TB) [20]. ReC were defined by exposure for� 5 h to an active TB
case� 6 months prior to enrollment. CoC were enrolled in the community and reported no
previous exposure or a remote exposure > 6 months before enrollment (Fig 2). LTBI was
assessed by Interferon Gamma Release Assays (IGRA) [QuantiFERON-Gold-in-tube or Quan-
tiFERON-plus (Qiagen, Germantown, MD) or T-SPOT.TB (Oxford Immunotec, Oxford)].
Socio-demographic information was recorded at enrollment as described previously [21].
Fig 1. Enrollment algorithm. Adults (A) and elderly (E) individuals identified in the community (Community controls, CoC),
or in pulmonary clinics as newly-diagnosed pulmonary TB patients (TB), or contacts of TB cases with reported exposure�6
months before enrollment (Recent contacts, ReC), were invited to participate. TB diagnosis was based on laboratory findings
(positive culture and/or acid-fast sputum smear) or clinical criteria based on physician diagnosis and abnormal chest X-ray.
LTBI, Latent TB infection. aExclusion based on HIV infection, excessive alcohol use, and drug abuse, with some having more
than one of these conditions. bExclusion due to unknown LTBI status, non-tuberculosis mycobacteria (NTM) or pulmonary TB
diagnosis ruled out/unclear.
https://doi.org/10.1371/journal.pone.0255194.g001
Fig 2. Definitions for community controls and recent contacts. Community controls were identified in the
community (not in pulmonary clinics) and reported no previous exposure or a remote exposure to a pulmonary TB
patient>6 months before enrollment. Recent contacts reported exposure to an active TB case�6 months before the
time of enrollment. Community controls and recent contacts with at least one positive IGRA assay were classified as
LTBI+, and when both negative, then as LTBI-.
https://doi.org/10.1371/journal.pone.0255194.g002
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Briefly, macrovascular and microvascular diseases, use of diabetes medications in the past
month, or taking non-steroidal anti-inflammatory drugs (NSAIDs) in the past week was based
on self-reporting. Excessive alcohol intake was based on a validated questionnaire [22]. Drug
abuse was self-reported as daily or weekly use of recreational injectable or non-injectable
drugs. Diabetes was based on hyperglycemia (fasting�126 mg/dL in most cases, or random
�200 mg/dL), chronic hyperglycemia (HbA1c�6.5%), or self-reported diagnosis [23]. Predia-
betes was based on HbA1c between 5.7% and 6.4% or fasting glucose between 110 and 125
mg/dL. HIV infection was based on self-reporting in non-TB cases, or blood test confirmed in
TB patients. Total cholesterol, HDL cholesterol and triglycerides were determined using Lipid
Panel Test Strips (PTS Diagnostics), and low-density cholesterol (cLDL) was calculated [24].
Data analysis
The study design followed the STROBE guidelines [25]. Data were entered into Microsoft
Access and exported into SAS version 9.4 (Cary, NC) for quality control and analysis. Addi-
tional analyses were performed using GraphPad Prism version 9.0 (La Jolla, CA). Categorical
variables were compared with the Chi-square or Fisher’s exact test. Continuous variables were
analyzed for differences in medians using Wilcoxon test or Kruskal-Wallis with Dunn’s multi-
ple comparisons test for> 2 groups. For multivariable logistic regression models, variables
were selected based on a p value� 0.099 or biological relevance. Given the low incidence of
TB in our study population, we report odds ratios and refer to them as risk factors given their
close approximation to risk ratios [17]. Significance was set as p� 0.050 and marginal signifi-
cance at p� 0.099.
Results
Participant enrollment and characteristics
A total of 744 participants were enrolled (549 adults and 195 elderly). Adults that had a higher
prevalence of HIV, excessive alcohol consumption or drug abuse, were excluded given our pri-
mary interest in identifying risk factors for TB in the elderly (Fig 1). We further excluded TB
suspects with non-tuberculous mycobacteria, unclear or ruled out TB, or ReC with unknown
LTBI status. The remaining 646 participants comprised 123 new-diagnosed pulmonary TB (43
elderly and 80 adults), 381 ReC (80 elderly and 301 adults), and 142 CoC (60 elderly and 82
adults; Fig 1). More than half of the participants were females (62.8%) and 72.9% married.
Only 39% had an education beyond middle school, 74.8% had health insurance, 71.2% were
non-smokers with only 12.6% current smokers. Two-thirds were obese or overweight (66.1%),
71.9% had central obesity, and 28.9% had diabetes (98% type 2 diabetes). Most were BCG vac-
cinated (88.5%) at birth, and only 2.5% had a history of TB (Table 1).
Age-associated characteristics amongst non-TB or TB participants
We first sought to identify host characteristics that distinguished elderly vs. adult groups, given
their higher risk of active TB, or adverse TB outcomes [11, 12, 26]. When analyzing the non-
TB groups (CoC and ReC groups), we found that most of the characteristics that distinguished
the elderly from adults were similar (S1 Table). Therefore, for most analysis we merged both
groups into one ‘non-TB category’. An exception was the analysis related to LTBI given its
higher prevalence in the elderly vs. adults among CoCs (E 55.0% vs. A 23.2%; p <0.001), but
similarity in ReCs (E 64.1% vs. A 71.3%; p 0.233; S1 Fig; S1 Table).
Among the non-TB participants, the following features distinguished the elderly vs. adults
(Table 1; S1 and S2 Figs). Regarding socio-demographics, the elderly had differences in marital
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status (mostly widowed; p<0.001) and socioeconomic indicators [lower education (p<0.001)
and smaller family size (p<0.001), but higher frequency of health insurance (p = 0.004)].
Regarding health conditions, the elderly had a higher prevalence of diabetes and pre-diabetes
Table 1. Characteristics of the elderly vs. adults, by TB study groups.
All Non-TB TB
Adults Elderly Adults Elderly
n % or n % or n % or median
(IQR)
p value n % or median
(IQR)








Age, in years 646 43.0 (28.0) 383 38 (14) 140 67 (10.5) <0.001 80 37.0 (21.0) 43 68.0 (11.0) <0.001
Male sex 240 37.2% 126 32.9% 38 27.1% 0.209 45 56.3% 31 72.1% 0.085
Marital status <0.001 0.003
Never married 104 16.1% 68 17.8% 7 5.0% 21 26.3% 8 18.6%
Ever married � 471 72.9% 306 79.9% 84 60.0% 56 70.0% 25 58.1%
Widowed 71 11.0% 9 2.3% 49 35.0% 3 3.8% 10 23.3%
Smoking 0.716 0.099
Never 459 71.2% 284 74.2% 106 75.7% 49 62.0% 20 46.5%
Past or Current 186 28.8% 99 25.8% 34 24.3% 30 38.0% 23 53.5%
Smoking—pack per year 644 0.01 (0.40) 383 0 (0.1) 140 0 (0.0) 0.697 79 0.01 (1.50) 42 0.55 (5.10) 0.017
Socioeconomic indicators
Highest education <0.001 <0.001
Up to Middle School 394 61.0% 197 51.4% 113 80.7% 46 57.5% 38 88.4%
High School or College 252 39.0% 186 48.6% 27 19.3% 34 42.5% 5 11.6%
Health insurance 482 74.8% 269 70.2% 116 82.9% 0.004 66 82.5% 31 73.8% 0.259
Household family size 566 4.0 (2.0) 331 4.0 (2.0) 119 3.0 (3.0) <0.001 81 4.0 (2.0) 38 3.0 (4.0) 0.228
Health conditions
Diabetes (2 categories) 187 28.9% 69 18.0% 66 47.1% <0.001 31 38.8% 21 48.8% 0.280
Diabetes (3 categories) <0.001 <0.001
No diabetes 311 48.1% 233 60.8% 32 22.9% 39 48.8% 7 16.3%
Pre-diabetes 148 22.9% 81 21.1% 42 30.0% 10 12.5% 15 34.9%
Diabetes 187 28.9% 69 18.0% 66 47.1% 31 38.8% 21 48.8%
Obesity, BMI 646 27.2 (7.5) 383 28.6 (7.5) 140 27.8 (6.9) 0.266 80 22.2 (7.0) 43 21.7 (5.5) 0.443
Obesity, BMI categories 0.148 0.125
Under/Normal (<24.9) 219 33.9% 86 22.5% 40 28.6% 57 71.3% 36 83.7%
Over/Obese (�25) 427 66.1% 297 77.5% 100 71.4% 23 28.8% 7 16.3%
WHR (M� 0.90; F
�0.86)
454 71.9% 284 74.2% 111 79.3% 0.399 37 47.4% 22 52.4% 0.078
Macrovascular diseases 153 23.7% 51 13.3% 80 57.1% <0.001 7 8.4% 15 34.9% <0.001
Microvascular diseases 169 26.2% 68 17.8% 65 46.4% <0.001 20 24.1% 18 41.9% 0.040
NSAIDs in past week 128 23.3% 48 12.5% 40 28.6% <0.001 24 31.2% 16 42.1% 0.247
TB-related conditions
Past TB 13 2.5% 9 2.3% 4 2.9% 0.742 10 12.1% 4 9.3% 0.642
Latent TB infection �� 211 55.1% 212 55.4% 91 65.0% 0.048 N/A N/A
BCG vaccine 570 88.5% 341 89.0% 131 93.6% 0.158 70 87.5% 28 65.1% 0.003
Data expressed as column % for categorical variables or median (interquartile range, IQR) for continuous; Normal range values for each parameter shown in parenthesis
� Ever married includes married, cohabitation, divorced or separated; NSAIDs, non-steroidal anti-inflammatory drugs; WHR, waist-hip ratio or Central obesity; M,
Male; F, Female; p values� 0.099 shown in bold
�� Latent TB infection based on a positive T-Spot.TB or QuantiFERON assay, LTBI only evaluated in non-TB study groups; BMI, Body-mass index
https://doi.org/10.1371/journal.pone.0255194.t001
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(p<0.001), LTBI (p 0.048), macrovascular and microvascular diseases (p<0.001), and use of
anti-inflammatory medications (p<0.001). Glucose-related measurements (Table 2) were
higher (hyperglycemia and HbA1c; p<0.001) which is consistent with their diabetes status.
Lipid profiles (total, LDL and HDL cholesterols and triglycerides) were also higher in the
elderly (Table 2). Regarding hematology indices, the elderly had higher eosinophils (p = 0.045)
but lower platelets (p<0.001) and hemoglobin levels (p 0.047; S2 Table).
Among TB patients, the following characteristics were significantly different between the
elderly and adults (Table 1 and S1 Fig). Regarding sociodemographics, there was a higher prev-
alence of males (p = 0.085), widowed status (p = 0.003) and smoking-packs per year
(p = 0.017) in the elderly. Regarding socioeconomics, the elderly had a lower education (p
<0.001). Regarding health-related conditions, the elderly had more pre-diabetes or diabetes (p
<0.001), macrovascular (p<0.001) and microvascular (p = 0.040) diseases, and lower preva-
lence of BCG vaccination (p = 0.003). Regarding lipid- and glucose-related measurements,
there were no differences (Table 2). Regarding hematology indices, the ratios of neutrophils/
lymphocytes and monocytes/lymphocytes were higher in the elderly (S2Table and S2 Fig).
Altogether, we found that known risk factors for TB in adults, such as lower education and
dysglycemias, were significantly higher in the elderly vs. adults with or without TB [27, 28]. In
the elderly, pre-diabetes and diabetes accounted for an overall 76.6% in non-TB and 83.7% in
TB cases. Given the high prevalence of dysglycemias, we further examined if these were associ-
ated with TB status in our cohort.
Risk factors for TB in the elderly
In order to determine if diabetes or other host characteristics are risk factors for TB in our
elderly Hispanic cohort, we compared the elderly who had TB vs. those who did not (S3 Table
and S3 Fig). For diabetes and related conditions, the elderly TB participants had lower preva-
lence of impaired fasting glucose (4.7 vs. 15.7%) or hyperglycemia (20.9 vs. 28.6%; p = 0.058).
Table 2. Lipid and glucose profiles in elderly vs. adults, by TB status.
Non-TB TB
Adults Elderly Adults Elderly
n % n % p valuea n % n % p value
Lipid profiles, (mg/dl)b
High cholesterol (200) 48 12.6% 29 20.9% 0.020 5 6.3% 1 2.3% 0.335
Low HDL (40 M, 50 F) 287 75.1% 90 64.7% 0.019 58 72.5% 33 76.7% 0.609
High LDL (100) 144 38.0% 65 46.8% 0.072 15 18.8% 6 14.0% 0.500
High Triglycerides (150) 97 25.3% 46 32.9% 0.087 6 7.5% 3 7.0% 0.915
Glucose-related measurements
Glycemia <0.001 0.153
Normoglycemia 295 78.0% 77 55.4% 45 57.0% 32 74.4%
Impaired Fasting Glucose 28 7.4% 22 15.8% 8 10.1% 2 4.7%
Hyperglycemia 55 14.6% 40 28.8% 26 32.9% 9 20.9%
Chronic hyperglycemia, HbA1c <0.001 0.144
Normal (<5.7%) 235 61.4% 36 25.7% 39 48.8% 8 18.6%
Pre-diabetes (5.7–6.4%) 89 23.2% 56 40.0% 11 13.8% 18 41.9%
Chronic hyperglycemia (� 6.5%) 59 15.4% 48 34.3% 30 37.5% 17 39.5%
a p values� 0.099 shown in bold
b Normal range values for each parameter shown in parenthesis. Abbreviations: M, Male; F, Female.
https://doi.org/10.1371/journal.pone.0255194.t002
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Regarding obesity and lipid profiles, the elderly with TB vs. no TB, had a higher prevalence of
lower BMI and low central obesity (p<0.001), lower total cholesterol (p = 0.004), LDL choles-
terol (p<0.001) and triglycerides (p<0.001). Regarding socio-demographics, the elderly with
TB had a higher proportion of males or smoking index (p<0.001). The elderly TB participants
had a lower prevalence of BCG vaccination (p<0.001) or macrovascular diseases (p = 0.011).
To determine if these host characteristics were independently associated with TB in the
elderly, we conducted a multivariable logistic regression analysis. In our initial model 1, we
evaluated glycemia as a diabetes-defining variable, together with sex, smoking history, BCG
vaccination and BMI (selected from the variables defining obesity and lipid profiles). Our anal-
ysis showed that hyperglycemia and impaired fasting glucose were not associated, while male
sex, BCG vaccination and BMI remained independently associated with TB, and smoking was
associated when modeling ‘past’ vs. ‘never or current’ TB (Table 3; Fig 3). Given the unex-
pected association with BCG vaccination, in model 2 we removed BMI and dysglycemia since
they could be a consequence of TB. However, absence of BCG vaccination remained associated
with risk of TB in the elderly, along with male sex and smoking.
Previous studies in adults, including our own, indicated that diabetes is a risk factor for TB,
and that BCG vaccination does not confer protection for TB development [17, 29]. To confirm
if these findings would hold in our adult cohort, we ran the same multivariable models as
described for the elderly. Our findings confirmed that in adults there are higher odds of hyper-
glycemia (adj-OR 4.37, 95% CI 2.22, 8.58) or impaired fasting glucose (adj-OR 5.84, 95% CI
Table 3. Univariable and multivariable models for odds of TB vs. non-TB patients by host characteristics, in the elderly or adults.
Elderly: TB vs non-TB Adults: TB vs non-TB
OR (95% CI) Model 1 a: Model 2
b:





Adj-OR (95% CI) Exclude
BMI,
glycemia
Adj-OR (95% CI) Exclude
BMI,
glycemia
Male vs female sex 6.93 (3.23, 14.87) 3.92 (1.41, 10.88) 4.33
(1.76,
10.65)
2.65 (1.61, 4.37) 2.80 (1.49, 5.25) 2.63
(1.56,
4.46)
Smoking, ’Past’ vs ’current or never’ 5.37 (2.46, 11.70) 5.43 (1.627, 18.122) 2.55
(1.008,
6.449)
4.71 (2.68, 8.29) 5.41 (2.57, 11.38) 3.99
(2.21,
7.19)
BCG vaccine, No vs Yes 7.86 (3.13, 19.74) 5.36 (1.68, 17.10) 6.15
(2.24,
16.92)




Normoglycemia 1.0 1.0 1.0 1.0
Impaired Fasting Glucose 0.22 (0.05, 0.99) 0.38 (0.06, 2.38) 2.11 (0.93, 4.76) 5.84 (2.07, 16.49)
Hyperglycemia 0.54 (0.24, 1.25) 0.52 (0.18, 1.46) 3.30 (1.92, 5.80) 4.37 (2.22, 8.58)
Diabetes 1.07 (0.54, 2.12) 2.88 (1.71, 4.84)
Obesity
Underweight/normal 12.99 (5.34, 31.58) 12.34 (4.44, 34.33) 9.01 (5.26, 15.42) 14.30 (7.48, 27.32)
Overweight/Obese 1.0 1.0 1.0 1.0
a Model-1. Controlled for all variables in the table.
b Model-2. Model 1, except for BMI and glycemia; 95% CI with p values� 0.099 shown in bold; In sensitivity analysis, additional models were evaluated: Model 1A.
When glycemia was replaced by diabetes (2 categories) in Model 1, diabetes remained associated with TB in adults (adj-OR 4.08, 95% CI 2.13, 7.80), but not in the
elderly [adj-OR 1.70 (0.65, 4.45)]. Model 1B. Addition of education or health insurance did not modify the associations already observed in Model 1.
https://doi.org/10.1371/journal.pone.0255194.t003
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2.07, 16.49) in TB patients (model 1), and a lack of association between TB and BCG vaccina-
tion (models 1 and 2; Table 3 and Fig 3). Past smoking, male sex and lower BMI were also asso-
ciated with TB in both models (Fig 3).
Host factors associated with BCG vaccination
Given our observed protective effect of BCG vaccination for TB in the elderly (Fig 3), we evalu-
ated if there was another host characteristic associated with BCG vaccination that we had not
identified, that could influence TB risk (e.g. a confounding factor; S4 Table). Among all study
participants, BCG vaccination was more prevalent in females vs. males (p 0.014), non-TB vs.
TB participants (p<0.001), individuals with higher education (p = 0.027) and access to health
insurance (p 0.027). After controlling for age, sex and TB, BCG vaccination remained associ-
ated with higher education level and access to health insurance. Therefore, we expanded the
multivariable analysis shown in Fig 3, by adding education or health insurance to the models.
However, neither of these variables affected the associations already noted, i.e. risk of TB and
lack of BCG vaccination, and the lack of association with diabetes, among the elderly.
Clinical characteristics of the elderly with TB
Since the diagnosis of TB can be challenging in the elderly [30], we also evaluated whether the
elderly differed in their microbiological or clinical presentation of active TB when compared
Fig 3. Multivariable logistic regression models of odds of TB vs non-TB among adults or elderly, for different
host characteristics. Host characteristics with a p value�0.09 by univariable analysis were selected as indicated in the
text for model 1. For model 2, BMI and glycemia were removed from model 2, given that they may be modified once
TB develops. Graphs show odds ratio with Wald 95% CI. Abbreviations: IFG, impaired fasting glucose; UW,
underweight (BMI<18.5); OW/OB, overweight/obese (BMI>25); BMI, body-mass index; BCG, Bacillus Calmette-
Guérin vaccinated.
https://doi.org/10.1371/journal.pone.0255194.g003
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to adults. Our results showed no significant differences in sputum acid-fast smear results or
grade, nor the proportion with positive culture (Table 4). Signs and symptoms were similar for
cough, productive cough, hemoptysis, chest pain or weight loss, but other important distin-
guishing features were observed in the elderly. Namely, elderly participants were less likely to
report fever or chills, and had a longer history of cough or weight loss prior to TB diagnosis.
Characteristics of the elderly with LTBI
Among the elderly CoC group, more than half had LTBI (Table 1), which puts them at higher
risk for TB reactivation when compared to non-infected elderly [4]. However, we did not find
any host factor associated with LTBI status among elderly CoC. Furthermore, among elderly
ReC there were few differences when comparing positive vs. negative LTBI (S5 Table).
Discussion
We conducted a cross-sectional study to identify unique aspects of TB and LTBI in elderly His-
panics from the Texas-Mexico border region. TB risk factors such as HIV/AIDS, excess alco-
hol use and drug abuse were more prevalent in adults, and were excluded from analysis. We
found that few host factors were associated with LTBI status. In contrast, the elderly had a
higher prevalence of birth cohort characteristics that are known risk factors for active TB in
adults, such as diabetes and lower education [31, 32]. Interestingly, despite the high prevalence
of diabetes in the elderly population, we found that it was not associated with TB. Instead,
being male, smoking and having a low BMI were risk factors for TB in the elderly. An addi-
tional unexpected finding was the protective effect of BCG vaccination at birth in the elderly.
Our finding that diabetes is not a risk factor for TB in the elderly contrasts with numerous
studies in adults, including our own, where diabetes patients have a 1.5 to 3-fold higher risk of
TB [15, 17, 33]. We confirmed that adult diabetes patients have a higher risk of TB, and we
Table 4. TB diagnostic criteria and signs and symptoms, by age groups.
Diagnostic criteria
Adults Elderly
n (%) n (%) p value
Positive AFB Smear 75 (91.5%) 39 (90.7%) 1.000
AFB Smear grade 0.581
Negative or 1+ 40 (49.4) 19 (44.2)
2+ or 3+ 41 (50.6) 24 (55.8)
TB diagnosis 0.319
Clinical 10 (12.1%) 8 (18.6%)
Laboratory confirmed 73 (87.9%) 35 (81.4%)
Signs and symptoms Presence Duration
Adults Elderly Adults Elderly
n (%) n (%) p value Days Days p value
Cough 79 (95.2%) 39 (92.9%) 0.687 70 (70) 90 (105) 0.071
Productive Cough 68 (85%) 35 (81.4%) 0.616 30 (40) 60 (70) 0.610
Hemoptysis 28 (35%) 13 (31%) 0.691 0 (3) 0 (1.5) 0.904
Fever/ Chills 67 (80.7%) 25 (58.1%) 0.007 7 (18) 7 (20) 0.612
Chest Pain 43 (51.8%) 21 (48.8%) 0.706 14 (30) 15 (30) 0.419
Weight Loss 59 (73.8%) 34 (79.1%) 0.660 30 (40) 60 (105) 0.015
NAP, Not applicable; p values� 0.099 shown in bold
https://doi.org/10.1371/journal.pone.0255194.t004
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further observed a higher risk of TB in adults with impaired fasting glucose. However, hyper-
glycemia and impaired fasting glucose were not associated with TB in the elderly. In fact,
impaired fasting glucose was protective by univariable analysis. A reduced strength in the asso-
ciation between TB and diabetes has been noted in past studies, but its implications for the
elderly population have not been explicitly evaluated in multivariable models [14, 15]. In fact,
diabetes continues to be regarded as a risk factor for TB among the elderly [34, 35]. We specu-
late that in the elderly, the lack of an association between type 2 diabetes and TB is explained
by differences in the underlying pathophysiology of diabetes. Type 2 diabetes in the elderly is
characterized by a milder hyperglycemia due to delayed responsiveness of pancreatic beta cells
to release insulin versus high levels of insulin, insulin resistance and a more severe hyperglyce-
mia in adults. We also cannot rule out a survivor effect of well-controlled diabetes in our
elderly cohorts. We are currently evaluating these distinctions.
In experimental models, BCG vaccine can extend the survival of diabetic mice infected with
M.tb through reduced immunopathology, potentially mediated by Th2/M2-mediated mecha-
nisms [36]. Although these studies only evaluated mice for one year, equivalent to mid-life for
mice [37], we can perhaps extrapolate that BCG would also afford older diabetic mice protec-
tion from TB. Specific studies to address BCG and diabetes in the context of TB have not been
performed, but BCG vaccination of old mice [38] and guinea pigs [39] does provide protection
against TB. Our findings raise the need to evaluate the occurrence of dysglycemia in old mice,
and document its relationship to TB risk. Despite the lack of association between diabetes and
TB in the elderly population, we recommend the screening for diabetes in all newly diagnosed
elderly TB patients given that management of acute hyperglycemia is important for proper
immune function against M. tuberculosis [40–42]. Furthermore, diabetes may be associated
with adverse TB treatment outcomes in the elderly, as is the case for adults [5, 43].
Our findings showed a lack of association between BCG vaccination and TB in adults,
which is consistent with the literature [44]. However, a novel observation in our study was that
the elderly with history of BCG vaccination were less likely to have TB. BCG may confer pro-
tection against LTBI in adults [45], but is mostly known for its protective effect against dissem-
inated TB in children [46]. We are not aware of any other documentation that BCG
vaccination at birth will confer protection from TB in elders. A recent meta-analysis concluded
that BCG confers protection against TB shortly after vaccination, and hence, its effect is most
notable in children but not in adults in high burden settings. Their results in adults do not sup-
port our findings, but there is limited data in individuals beyond 60 years of age [47]. Confir-
mation of our findings in other elderly cohorts would open the possibilities for considering a
booster BCG in the elderly. Indeed, BCG induces a non-specific protective effect against other
microbial infections in young children through the induction of long-lasting epigenetic
changes in the bone marrow myeloid precursor for monocytes, a process known as trained
immunity [48]. Evidence for BCG-induced trained immunity in elderly individuals was
recently demonstrated by the ACTIVATE trial, in which BCG vaccination of individuals 65
years and older lowered the risk of viral respiratory infections [49], although preliminary anal-
ysis of the BCG-PRIME study shows no protection against COVID-19 [50]. We speculate that
BCG-induced trained immunity at birth confers a “baseline” protection against active TB
development that persists throughout life. This “baseline” protection is most notable when the
immune system is still immature in newborns, and when it wanes in the elderly, but not in
other age groups where other aspects of the immune system, including adaptive immunity,
play a prominent role in M.tb infection control. Consistent with this possibility, BCG at birth
can confer heterologous protection against other respiratory infections, potentially further
shaping the pulmonary immune system through adult and elderly life [51].
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TB delayed diagnosis or misdiagnosis and high mortality rates in the elderly are attributed
to their increased likelihood of absent, altered, or delayed clinical symptoms, presence of age-
associated conditions such as cognitive impairment, and clinical symptoms shared by active
TB and old age such as fatigue, and weight loss [5, 30, 52, 53]. In our elderly cohort, we found
clinical differences such as a lower prevalence of fever and chills, and longer duration of cough
and weight loss. In fact, several elderly TB patients died prior to enrollment in our study or TB
treatment initiation. There is a need for biomarkers to enhance TB diagnosis and prognosis in
this population. Candidates include the higher neutrophil/lymphocyte and monocyte/lympho-
cyte ratios observed by others and us, associated with more severe TB in adults [54–59].
Study limitations are the small sample size of our elderly cohort, particularly for some sub-
analysis. We also defined elderly participants as those 60 years and older, but TB risk increases
with age among the elderly, with waning representation in the oldest age groups [4]. Our study
could be affected by survival bias, with some TB patients dying prior to enrollment.
In summary, our findings in elderly Hispanics confirm the presence of shared risk factors
for TB with adults, such as being male, smoking and low BMI. Importantly, our findings high-
light differences between age groups, notably the lack of an association between TB and diabe-
tes, and the potential protective effect of BCG vaccination in the elderly population. Despite its
low prevalence in our study population, smoking was another independent risk factor for TB
that deserves further evaluation in other elderly cohorts. Our results call for future studies in
the elderly population, for tailored identification of risk factors for LTBI, active TB or adverse
TB outcomes, in this unique, heterogeneous, vulnerable and understudied population.
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